Ligand Pharmaceuticals Inc
LGNXZ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000886163
In the last 90 days, Ligand Pharmaceuticals Inc insiders filed 0 open-market purchases and 5 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Ligand Pharmaceuticals Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 1 | 1 | 0 |
| Shares | 500 | 500 | 0 (0.0%) |
| Value | $0 | $0 | $0 |
New holders (0)
Institutions that held Ligand Pharmaceuticals Inc at the end of Q2 2022 but not at the end of Q1 2022.
None.
Sold out (0)
Institutions that held Ligand Pharmaceuticals Inc at the end of Q1 2022 and filed for Q2 2022 without it.
None.